Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration.

Brantley MA, Edelstein SL, King JM, Apte RS, Kymes SM, Shiels A
Am J Ophthalmol. 2007 144 (3): 404-408

PMID: 17631852 · PMCID: PMC2140051 · DOI:10.1016/j.ajo.2007.05.018

PURPOSE - To determine whether the complement factor H (CFH) Y402H variant is associated with specific age-related macular degeneration (AMD) clinical phenotypes.

DESIGN - Retrospective, case-control study.

METHODS - One hundred and eighty-eight white subjects with AMD and 189 control subjects were genotyped for the T-to-C polymorphism in exon 9 of the CFH gene by restriction-fragment length analysis and deoxyribonucleic acid (DNA) sequencing using genomic DNA from mouthwash samples. AMD phenotypes were characterized by clinical examination, fundus photography, and fluorescein angiography.

RESULTS - Heterozygosity for the at-risk genotype (TC) increased the likelihood for AMD 2.1-fold (95% confidence interval [CI], 1.3 to 3.3), whereas homozygosity for the genotype (CC) increased the likelihood for AMD 6.5-fold (95% CI, 3.4 to 12.5) in our population. The C allele was associated significantly with predominantly classic choroidal neovascularization (odds ratio [OR], 2.01; 95% CI, 1.34 to 3.30). Neovascular lesion size was similar among the three genotypes (P = .67).

CONCLUSIONS - The Y402H CFH variant carried a significantly increased risk for developing AMD in our population. Genotype and phenotype correlations regarding choroidal neovascular lesion type were observed.

MeSH Terms (17)

Aged Case-Control Studies Choroidal Neovascularization Complement Factor H Exons Female Fluorescein Angiography Genetic Variation Genotype Humans Macular Degeneration Male Phenotype Polymorphism, Restriction Fragment Length Polymorphism, Single Nucleotide Retrospective Studies Sequence Analysis, DNA

Connections (1)

This publication is referenced by other Labnodes entities: